Chronic opioid use is associated with early biologic discontinuation in inflammatory bowel disease

Chronic opioid use is associated with poorer clinical outcomes in inflammatory bowel disease.

[1]  M. Fitzcharles,et al.  All-cause mortality in patients with long-term opioid therapy compared with non-opioid analgesics for chronic non-cancer pain: a database study , 2020, BMC Medicine.

[2]  A. Cheifetz,et al.  Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease. , 2019, Gastroenterology & hepatology.

[3]  Elizabeth A. Scoville,et al.  Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease. , 2019, Inflammatory bowel diseases.

[4]  K. Verhamme,et al.  Are we facing an opioid crisis in Europe? , 2019, The Lancet. Public health.

[5]  S. Saini,et al.  Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel Diseases , 2018, The American Journal of Gastroenterology.

[6]  D. Hommes,et al.  Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial , 2017, The Lancet.

[7]  R. West,et al.  Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  T. Teunis,et al.  An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: is Europe next? , 2017, The bone & joint journal.

[9]  S. Walsh,et al.  Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's Disease , 2017, Inflammatory bowel diseases.

[10]  Harminder Singh,et al.  Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study , 2016, Inflammatory bowel diseases.

[11]  F. Remzi,et al.  Association of Preoperative Narcotic Use With Postoperative Complications and Prolonged Length of Hospital Stay in Patients With Crohn Disease. , 2016, JAMA surgery.

[12]  James S. Williams,et al.  Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011 , 2014, PAIN®.

[13]  A. Macario,et al.  Economic burden of back and neck pain: effect of a neuropathic component. , 2014, Population health management.

[14]  A. Teriaky,et al.  Opioid Use is Associated with Decreased Quality of Life in Patients with Crohn's Disease , 2014, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[15]  B. Martin,et al.  The Role of Opioid Prescription in Incident Opioid Abuse and Dependence Among Individuals With Chronic Noncancer Pain: The Role of Opioid Prescription , 2013, The Clinical journal of pain.

[16]  J. Steiner,et al.  Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic Databases , 2013, Medical care.

[17]  Bradley C Martin,et al.  Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. , 2010, Drug and alcohol dependence.

[18]  G. Pasternak,et al.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. , 2009, The journal of pain : official journal of the American Pain Society.

[19]  Femida Gwadry-Sridhar,et al.  Calculating medication compliance, adherence and persistence in administrative pharmacy claims databases , 2008 .

[20]  David W. Hosmer,et al.  Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .

[21]  D. Drossman,et al.  The narcotic bowel syndrome: clinical features, pathophysiology, and management. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  M. Von Korff,et al.  Frequency and Priority of Pain Patients' Health Care Use , 2007, The Clinical journal of pain.

[23]  P. V. Rao,et al.  Applied Survival Analysis: Regression Modeling of Time to Event Data , 2000 .

[24]  Judith D. Goldberg,et al.  Applied Survival Analysis , 1999, Technometrics.

[25]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.

[26]  Richard G. Compton,et al.  Supporting Information Section , 2014 .

[27]  D. Hosmer,et al.  A Simplified Method of Calculating an Overall Goodness-of-Fit Test for the Cox Proportional Hazards Model , 1998, Lifetime data analysis.